SOAP Note for 24-Year-Old Female Annual Exam with Contraception Counseling
SUBJECTIVE
Chief Complaint: Annual well-woman examination; desires contraception counseling
History of Present Illness:
- 24-year-old G1P1 female, 6 months postpartum
- Requesting birth control options
- Reports hair loss/shedding and extreme fatigue since delivery
- Menstrual cycles have resumed and are regular
- Denies current medications
- Denies past medical history
Review of Systems:
- Constitutional: Extreme fatigue
- Integumentary: Hair shedding/loss
- Gynecologic: Regular menses, no abnormal bleeding
OBJECTIVE
Vital Signs: [Document BP, HR, Temp, Weight]
Physical Examination:
- General: Well-appearing female in no acute distress
- [Document pertinent physical exam findings]
Laboratory:
- Urine pregnancy test: Negative (performed in office)
ASSESSMENT
- Encounter for contraceptive counseling (Z30.09)
- Postpartum telogen effluvium (L65.0) - hair shedding at 6 months postpartum is consistent with normal postpartum hair loss
- Postpartum fatigue (O90.89) - extreme fatigue at 6 months postpartum warrants evaluation but may be related to infant care demands
PLAN
Contraception
Yasmin (drospirenone 3 mg/ethinyl estradiol 0.03 mg) prescribed - one tablet daily for 21 days followed by 7 inert tablets 111. This combined hormonal contraceptive (CHC) can be initiated today given negative pregnancy test 2. Yasmin demonstrates high contraceptive efficacy with Pearl Index of 0.41-0.71 3 and is well-tolerated with typical COC side effects 1.
Counseling provided:
- No examinations beyond pregnancy testing required before CHC initiation per CDC guidelines 2
- Common side effects: spotting/breakthrough bleeding (most common in first cycles, decreases to 6% by cycle 26), nausea, breast tenderness, headache 13
- Serious warning signs (ACHES): Abdominal pain, chest pain, severe headache, eye problems/vision changes, severe leg pain - seek immediate care 1
- Take one tablet daily at same time; if missed, follow package instructions
- Does not protect against STIs; barrier methods recommended if at risk
- May discontinue anytime if pregnancy desired 1
Postpartum Hair Loss
- Reassurance provided that postpartum telogen effluvium typically peaks 3-6 months postpartum and resolves spontaneously by 12-15 months postpartum
- No specific treatment required; supportive care with gentle hair handling
Postpartum Fatigue
- Discussed sleep hygiene, infant sleep patterns, and support systems
- Consider checking CBC, TSH, ferritin if fatigue persists or worsens
- Follow-up if symptoms do not improve
Follow-Up
- Return in 3 months or sooner if concerns with contraception, persistent fatigue, or other symptoms
- Contact office immediately if warning signs develop
- Annual well-woman exam due in 1 year
CPT CODES
- 99385 - Initial comprehensive preventive medicine evaluation and management, age 18-39 years (if established patient, use 99395)
- 99213 or 99214 - Office visit for evaluation and management (if problem-focused visit for fatigue/hair loss warrants separate E&M)
- 81025 - Urine pregnancy test, by visual color comparison methods
ICD-10 CODES
- Z30.09 - Encounter for other general counseling and advice on contraception (primary)
- Z00.00 - Encounter for general adult medical examination without abnormal findings (if annual exam is primary reason)
- L65.0 - Telogen effluvium (postpartum hair loss)
- O90.89 - Other complications of the puerperium, not elsewhere classified (postpartum fatigue)
- Z34.90 - Encounter for supervision of normal pregnancy, unspecified, unspecified trimester (if documenting postpartum status; alternatively use Z39.2 for routine postpartum follow-up)
Note: The drospirenone component provides antimineralocorticoid and antiandrogenic properties that may offer additional benefits for mood, weight stability, and skin condition compared to other progestins 34. The 2024 CDC guidelines support same-day CHC initiation with negative pregnancy test without requiring pelvic examination or additional testing 2.